This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Anabolic steroids and hepatic effects

Authoring team

Hepatic:

  • various abnormal liver function tests (elevated alkaline phosphatase, aminotransferases, conjugated bilirubin, and plasma proteins) have been associated with the use of anabolic androgenic steroids (AAS)

  • jaundice occasionally occurs as a result of hypersensitivity-type reaction and is usually seen after 2-5 months of therapy

  • cholestasis has been reported especially with the use of 17alpha-alkylated agents

  • in the majority of cases, the rise in transaminases is transient, with levels normalizing within a few weeks of discontinuation of AAS

  • peliosis hepatis and hepatocellular adenomas have been seen with the use of 17alpha-alkylated AAS

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page